MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis

Hai-qing Luo,Yan Wang,Jing Ren,Quan-ying Zhang,Yan Chen,Mei-hui Chen,Ning-xin Huang,Min-hua Wu,Xu-dong Tang,Xiang-yong Li

DOI: https://doi.org/10.1038/s41598-024-55123-4

IF: 4.6

2024-03-21

Scientific Reports

Abstract:Improving drug sensitivity is an important strategy in chemotherapy of cancer and accumulating evidence indicates that miRNAs are involved in the regulation of drug sensitivity, but the specific mechanism is still unclear. Our previous study has found that miR-296-5p was significantly downregulated in nasopharyngeal carcinoma (NPC). Here, we aim to explore whether miR-296-5p is involved in regulating cisplatin sensitivity in NPC by regulating STAT3/KLF4 signaling axis. The cell proliferation and clonogenic capacity of NPC cells were evaluated by CCK8 Assay and plate colony assay, respectively. The Annexin V-FITC staining kit was used to determine and quantify the apoptotic cells using flow cytometry. The drug efflux ability of NPC cells were determined by Rhodamine 123 efflux experiment. The expression of miR-296-5p, apoptosis-related genes and protein in NPC cell lines were detected by qPCR and Western blot, respectively. Animal study was used to evaluate the sensitivity of NPC cells to DDP treatment in vivo. Our results showed that elevated miR-296-5p expression obviously promoted the sensitivity of NPC cells to DDP by inhibiting cell proliferation and clonogenic capacity, and inducing apoptosis. In addition, we found that miR-296-5p inhibited the expression of STAT3 and KLF4 in NPC cells, while overexpression of exogenous STAT3 reversed miR-296-5p-mediated enhancement in cell death of DDP-treated NPC cells. In vivo studies further confirmed that miR-296-5p promotes the sensitivity of NPC cells to DDP treatment. miRNA-296-5p enhances the drug sensitivity of nasopharyngeal carcinoma cells to cisplatin via STAT3/KLF4 signaling pathway.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to improve the sensitivity of nasopharyngeal carcinoma (NPC) cells to the chemotherapeutic drug cisplatin (DDP). Specifically, the researchers explored whether miR - 296 - 5p enhances the sensitivity of nasopharyngeal carcinoma cells to cisplatin by regulating the STAT3/KLF4 signaling axis.

The research background indicates that although cisplatin is an effective chemotherapeutic drug that can inhibit tumor cell growth and induce apoptosis, its effectiveness in the treatment of nasopharyngeal carcinoma is limited by chemoresistance. Therefore, understanding the mechanism of cisplatin resistance and finding ways to improve its drug sensitivity are crucial for the development of effective nasopharyngeal carcinoma treatment methods. Previous studies have shown that microRNAs (miRNAs) are involved in regulating the chemosensitivity of tumor cells, and miR - 296 - 5p is significantly down - regulated in nasopharyngeal carcinoma and may function as a tumor suppressor. However, it is still unclear whether and how miR - 296 - 5p affects the sensitivity of nasopharyngeal carcinoma cells to cisplatin.

Through a series of in vitro experiments (such as CCK8 assay, colony - formation assay, flow cytometry analysis, Rhodamine 123 efflux assay, quantitative real - time PCR and Western Blot, etc.) and in vivo experiments (such as xenograft tumor models), the researchers found that:

1. **The up - regulation of miR - 296 - 5p significantly enhances the sensitivity of nasopharyngeal carcinoma cells to cisplatin**, which is manifested as the inhibition of cell proliferation and colony - formation ability, and the induction of cell apoptosis at the same time.
2. **miR - 296 - 5p enhances the sensitivity of nasopharyngeal carcinoma cells to cisplatin by targeting and inhibiting the expression of STAT3 and KLF4**. Further experiments showed that over - expressing exogenous STAT3 can reverse the miR - 296 - 5p - mediated enhancement of cisplatin sensitivity.
3. **In vivo experiments also confirmed that miR - 296 - 5p can enhance the sensitivity of nasopharyngeal carcinoma cells to cisplatin treatment**, reducing tumor volume and weight, and decreasing the expression levels of STAT3 and KLF4.

These results indicate that miR - 296 - 5p enhances the sensitivity of nasopharyngeal carcinoma cells to cisplatin by targeting and inhibiting the STAT3/KLF4 signaling pathway, providing a new potential strategy for improving the chemotherapeutic effect of nasopharyngeal carcinoma.